[Menu] [Previous] [Next]

TUTORIAL: Clinical PET Cases - Cardiology - Credits and References

 Use the "Menu" button to jump to the Let's Play PET Main Menu or click on the Next (right arrowhead) and Previous (left arrowhead) buttons to proceed sequentially through the topics and tutorials. Or, you can return to the Department of Molecular and Medical Pharmacology's Home Page.

Credits

 Material for this section was kindly provided by:

Jamshid Maddahi, M.D.
Dept. of Molecular and Medical Pharmacology
UCLA School of Medicine

Marcelo DiCarli, M.D.
Dept. of Molecular and Medical Pharmacology
UCLA School of Medicine

Farbod Asgharzadeh
Dept. of Molecular and Medical Pharmacology
UCLA School of Medicine

References

  1. Araujo L; Lammertsma A; Rhodes C; McFalls E; Iida H; Rechavia E; Galassi A; De Silva R; Jones T; Maseri A. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation, 1991, 83:875-85.

  2. Armbrecht J; Buxton D; Schelbert H. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation, 1990, 81:1594-605.

  3. Armbrecht, J, Buxton, D, Brunken, R, Phelps, M and Schelbert, H: Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation, 80:863-872, 1989.

  4. Bacharach, S, Douglas, M, Carson, R, Kalkowski, P, Freedman, N, Perrone-Filardi, P, Bonow, R: Three-dimensional registration of cardiac positron emission tomography attenuation scans. J Nucl Med, 34:311-321, 1993.

  5. Baumgartner, F, Barrio, J, Henze, E, Schelbert, H, MacDonald, N, Phelps, M, et al.: [13N] Labeled L-Amino Acids for in vivo Quantitative Assessment of Local Myocardial Metabolism. J Med Chem, 24:764-766, 1981.

  6. Bellina C; Parodi O; Camici P; Salvadori P; Taddei L; Fusani L; Guzzardi R; Klassen G; L'Abbate A; Donato L. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med, 1990, 31:1335-43.

  7. Bergmann S. Clinical applications of assessments of myocardial substrate utilization with positron emission tomography. Molec Cell Biochem, 1989, 88:201-9.

  8. Bergmann S; Herrero P; Markham J; Weinheimer C; Walsh M. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Amer Coll Cardiol, 1989, 14:639-52.

  9. Berry, J, Hoffman, J, Steenbergen, C, Baker, J, Floyd, C, Van Trigt, P, Hanson, M, Coleman, R: Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. J Nucl Med, 34:39-47, 1993.

  10. Bol A; Melin J; Vanoverschelde J; Baudhuin T; Vogelaers D; De Pauw M; Michel C; Luxen A; Labar D; Cogneau M; et al. Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation, 1993, 87:512-25.

  11. Brown M; Myears D; Bergmann S. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med, 1989, 30:187-93.

  12. Brunken, R and Schelbert, H: Positron emission tomography in clinical cardiology. Cardiol Clin , 7:607-29, 1989.

  13. Buxton D; Nienaber C; Luxen A; Ratib O; Hansen H; Phelps M; Schelbert H. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation, 1989, 79:134-42.

  14. Buxton D; Schelbert H. Measurement of regional glucose metabolic rates in reperfused myocardium. Am J Physiol, 1991, 261:H2058-68.

  15. Camici, P, Ferrannini, E, Opie, L: Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog. Cardiovasc. Dis., 32:217-238, 1989.

  16. Chan, S, Brunken, R, Czernin, J, Porenta, G, Kuhle, W, Krivokapich, J, et al.: Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Amer Coll Cardiol 20:979-85, 1992.

  17. Chan, S, Brunken, R, Phelps, M and Schelbert, H: Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med, 32:665-72, 1991.

  18. Choi, Y, Brunken, R, Hawkins, R, Huang, S-C, Buxton, D, Hoh, C, Phelps, M, Schelbert, H: Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med, 20:308-318, 1993.

  19. Choi, Y, Hawkins, R, Huang, S, Gambhir, S, Brunken, R, Phelps, M, et al.: Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med , 32:733-738, 1991.

  20. Choi, Y, Huang, S-C, Hawkins, R, Kuhle, W, Dahlbom, M, Hoh, CK, Czernin, J, Phelps, M, Schelbert, H: A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med, 34:488-497, 1993.

  21. Cooper, J, Neumann, P, Mccandless, B. Detection of patient motion during tomographic myocardial perfusion imaging. J Nucl Med, 34: 1341-8, 1993.

  22. Delforge J; Syrota A; Lancon J; Nakajima K; Loch C; Janier M; Vallois J; Cayla J; Crouzel C. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med, 1991, 32:739-48.

  23. Delforge, J, Le Guludec, D, Syrota, A, Bendriem, B, Crouzel, C, Slama, M, Merlet, P: Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med, 34:981-991, 1993.

  24. Deussen A; Henrich M; Hamacher K; Borst M; Herzog H; Coenen H; Stocklin G; Feinendegen L; Schrader J. Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med, 1992, 33:2138-44.

  25. Gambhir, S, Schwaiger, M, Huang, SC, Krivokapich, J, Schelbert, H, Nienaber, C, et al.: A simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and F-18 deoxyglucose. J Nucl Med , 30:359-366, 1989.

  26. Goldstein D; Chang P; Eisenhofer G; Miletich R; Finn R; Bacher J; Kirk K; Bacharach S; Kopin I. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation, 1990, 81:1606-21.

  27. Gould, K, Schelbert, H, Phelps, M and Hoffman, E: Noninvasive detection of 47% diameter coronary stenosis by myocardial emission computed tomography of nitrogen-13 ammonia during pharmacologic coronary vasodilation in intact dogs. Front Nucl Med, 4-18, 1980.

  28. Grover-McKay, M, Ratib, O, Schwaiger, M, Wohlgelernter, D, Araujo, L, Nienaber, C, et al.: Detection of coronary artery disease with positron emission tomography and rubidium-82. Amer Heart J, 123:646-652, 1992.

  29. Henze, E, Huang, S, Ratib, O, Hoffman, E, Phelps, M and Schelbert, H: Quantitative compensation for cross-contamination of positron emission computed tomographs from cardiac studies with C-11 palmitate. Nucl Med CompAssist Funct Anal, 200-203, 1982.

  30. Henze, E, Schelbert, H, Barrio, J, Egbert, J, Hansen, H, MacDonald, N, et al.: Evaluation of Myocardial Metabolism with N-13 and C-11 Labeled Amino Acids for Positron Computed Tomography. J Nucl Med, 23:671-681, 1982.

  31. Herrero P; Markham J; Shelton M; Weinheimer C; Bergmann S. Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation, 1990, 82:1377-86.

  32. Hoff S; Stewart J; Frist W; Kessler R; Sandler M; Atkinson J; Votaw J; Carey J; Ansari M; Merrill W. Noninvasive detection of heart transplant rejection with positron emission scintigraphy. Ann of Thoracic Surg, 1992, 53:572-7.

  33. Hoffman J; Coleman R. Perfusion quantitation using positron emission tomography. Invest Radiol, 1992, 27 Suppl 2:S22-6.

  34. Huang, SC, Schwaiger, M, Carson, R, Carson, J, Hansen, H, Selin, C, et al.: Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. J Nucl Med , 26:616-25, 1985.

  35. Hutchins, G, Schwaiger, M, Rosenspire, K, Krivokapich, J, Schelbert, H and Kuhl, D: Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Amer Coll Of Cardiol, 15:1032-1042, 1990.

  36. Iida H; Rhodes C; de Silva R; Araujo L; Bloomfield P; Lammertsma A; Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med, 1992, 33:1669-77.

  37. Jeremy R; Links J; Becker L. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Amer Coll Cardiol, 1990, 16:695-704.

  38. Krivokapich J; Smith G; Huang SC; Hoffman E; Ratib O; Phelps M; Schelbert H. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation, 1989, 80:1328-37.

  39. Krivokapich, J, Barrio, J, Huang, SC, Phelps, M and Schelbert, H: Dynamic positron tomographic imaging with nitrogen-13 glutamate in patients with coronary artery disease: comparison with nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose imaging. J Amer Coll Cardiol, 16:1158-1167, 1990.

  40. Krivokapich, J, Huang, S, Ratib, O and Schelbert, H: Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. Amer Heart J, 122:202-211, 1991.

  41. Krivokapich, J, Stevenson, L, Kobashigawa, J, Huang, SC and Schelbert, H: Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Amer Coll Cardiol, 18:512-517, 1991.

  42. Kuhle W; Porenta G; Huang S; Buxton D; Gambhir S; Hansen H; Phelps M; Schelbert H. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation, 1992, 86:1004-17.

  43. Kuhle, W, Porenta, G, Huang, SC, Buxton, D, Gambhir, S, Hansen, H, et al.: Quantification of regional myocardial blood flow using N-13-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation , 86:1004-1017, 1992.

  44. Kuhle, W, Porenta, G, Huang, SC, Phelps, M and Schelbert, H: Issues in the quantitation of reoriented cardiac PET images. J Nucl Med, 33:1235-1242, 1992.

  45. Laubenbacher, C, Rothley, J, Sitomer, J, Beanlands, R, Sawada, S, Sutor, S, Muller, D, Schwaiger, M: An automated analysis program for the evaluation of cardiac PET studies: Initial results in the detection and localization of coronary artery disease using nitrogen-13 ammonia. J Nucl Med, 34:968-978, 1993.

  46. Lear JL; Ackermann RF. Quantification of patterns of regional cardiac metabolism. Radiology, 1990, 176:659-64.

  47. Markham J; Schuster J. Effects of nonideal input functions on PET measurements of pulmonary blood flow. J Appl Physiol, 1992, 72:2495-500.

  48. Marshall, R, Tillisch, J, Phelps, M, Huang, SC, Carson, R, Henze, E, et al.: Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation , 67:766-778, 1983.

  49. Martin GV; Caldwell J; Graham M; Grierson J; Kroll K; Cowan M; Lewellen T; Rasey J; Casciari J; Krohn K. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J Nucl Med, 1992, 33:2202-8.

  50. Merhige M; Garza D; Sease D; Rowe R; Tewson T; Emran A; Bolomey L; Gould K. Quantitation of the critically ischemic zone at risk during acute coronary occlusion using PET. J Nucl Med, 1991, 32:1581-6.

  51. Muzik, O, Beanlands, R, Hutchins, G, Mangner, T, Nguyen, N, Schwaiger, M: Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med, 34:83-91, 1993.

  52. Muzik, O, Beanlands, R, Wolfe, E, Hutchins, G, Schwaiger, M: Automated region definition for cardiac nitrogen-13-ammonia PET imaging. J Nucl Med, 34:336-344, 1993.

  53. Neely, J, Morgan, H: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann. Rev. Physiol., 36:413-459, 1974.

  54. Nienaber, C, Brunken, R, Sherman, C, Yeatman, L, Gambhir, S, Krivokapich, J, et al.: Metabolic And Functional Recovery Of Ischemic Human Myocardium After Coronary Angioplasty. J Amer Coll Cardiol, 18:966-978, 1991.

  55. O'Byrne G; Nienaber C; Miyazaki A; Araujo L; Fishbein M; Corday E; Schelbert H. Positron emission tomography demonstrates that coronary sinus retroperfusion can restore regional myocardial perfusion and preserve metabolism. J Amer Coll Cardiol, 1991, 18:257-70.

  56. Porenta, G, Kuhle, W, Czernin, J, Ratib, O, Brunken, R, Phelps, M, et al.: Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med, 33:1628-36, 1992.

  57. Raylman, R, Caraher, J, Hutchins, G: Sampling requirements for dynamic cardiac PET studies using image-derived input functions. J Nucl Med, 34:440-447, 1993.

  58. Schelbert, H, Henze, E, Schon, H, Keen, R, Hansen, W, Selin, C, et al.: C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography: III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J , 105:492-504, 1983.

  59. Schelbert, H, Phelps, M, Hoffman, E, Huang, S and Kuhl, D: Regional myocardial blood flow, metabolism and function assessed noninvasively by positron emission tomography. Am J Card , 46:1269-1277, 1980.

  60. Schelbert, H, Wisenberg, G, Phelps, M, Gould, K, Marshall, R, Hoffman, E, et al.: N-13 ammonia and positron emission computed axial tomography for the noninvasive assessment of coronary artery disease in man. Adv Clin Cardiol, 1:394-405, 1980.

  61. Schelbert, H and Czernin, J: Editorial: Noninvasive quantification of regional myocardial blood flow: Assessment of myocardial perfusion reserve and collateral circulation. J Nucl Med , 31:271-273, 1990.

  62. Schelbert, H and Schwaiger, M: PET studies of the heart. Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart , 12:581-661, 1986.

  63. Schelbert, H, Henze, E, Keen, R, Schon, H, Hansen, H, Selin, C, et al.: C-11 Palmitate for the Noninvasive Evaluation of Regional Myocardial Fatty Acid Metabolism with Positron Computed Tomography. IV In Vivo Evaluation of Acute, Experimentally Induced Myocardial Ischemia. Amer Heart J, 106:736-750, 1983.

  64. Schelbert, H, Henze, E, Sochor, H, Grossman, R, Huang, SC, Barrio, J, et al.: Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J , 111:1055-64, 1986.

  65. Schelbert, H, Wisenberg, G, Phelps, M, Gould, K, Henze, E, Hoffman, E, et al.: Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol , 49:1197-1207, 1982.

  66. Schelbert, H: Editorial: Euglycemic Hyperinsulinemic Clamp and Oral Glucose Load in Stimulating Myocardial Glucose Utilization During Positron Emission Tomography. J Nucl Med , 33:1263-1266, 1992.

  67. Schelbert, H: Positron emission tomography for the assessment of myocardial viability. Circulation , 84:1122-1131, 1991.

  68. Schwaiger, M, Brunken, R, Grover-McKay, M, Krivokapich, J, Child, J, Tillisch, J, et al.: Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol , 8:800-8, 1986.

  69. Schwaiger, M, Brunken, R, Krivokapich, J, Child, J, Tillisch, J, Phelps, M, et al.: Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J , 8:981-8, 1987.

  70. Shelton M; Dence C; Hwang D; Herrero P; Welch M; Bergmann S. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Amer Coll Cardiol, 1990, 16:477-85.

  71. Shelton M; Dence C; Hwang D; Welch M; Bergmann S. Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium. J Nucl Med, 1989, 30:351-8.

  72. Sochor, H, Schelbert, H, Schwaiger, M, Henze, E and Phelps, M: Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med , S66-9, 1986.

    Sokoloff, L, Reivich, M, Kennedy, C, et al: The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem., 28:897-916, 1977.

  73. Syrota A; Jehenson P. Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission. European J Nucl Med, 1991, 18:897-923.

  74. Tillisch, J, Brunken, R, Marshall, R, Schwaiger, M, Mandelkern, M, Phelps, M, et al.: Reversibility of cardiac wall motion abnormalities predicted by positron tomography. New Engl J Med, 314:884-888, 1986.

  75. Vaghaiwalla Mody, F, Brunken, R, Stevenson, L, Nienaber, C, Phelps, M and Schelbert, H: Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Amer Coll Cardiol 17:373-383, 1991.

  76. Walsh M; Geltman E; Brown M; Henes C; Weinheimer C; Sobel B; Bergmann S. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med, 1989, 30:1798-808.

  77. Warner-Stevenson, L, Bellil, D, Grover-McKay, M, Brunken, R, Schwaiger, M, Tillisch, J, et al.: Effects of afterload reduction on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy (diuretics and vasodilators). Am J Cardiol , 60:654-658, 1987.

Return to Top of References